Effects of stimulant medications on the EEG of children with Attention-Deficit/Hyperactivity Disorder predominantly inattentive type

International Journal of Psychophysiology

Volumn 47, Issue 2, 2003, Pages 129-137

  Clarke, Adam R ^a   Barry, Robert J ^a   McCarthy, Rory ^b   Selikowitz, Mark ^b   Brown, Christopher R ^a   Croft, Rodney J ^c  

^a UNIVERSITY OF WOLLONGONG   (Australia)

^b Private Practice   (Australia)

^c SWINBURNE UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

Attention Deficit Hyperactivity Disorder; Children; EEG; Medication; Stimulants

Indexed keywords

CENTRAL STIMULANT AGENT; DEXAMPHETAMINE; METHYLPHENIDATE;

ADOLESCENT; AROUSAL; ARTICLE; ATTENTION DEFICIT DISORDER; BRAIN CORTEX; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; ELECTROENCEPHALOGRAPHY; EYELID CLOSURE; FOURIER ANALYSIS; HUMAN; MALE; SCHOOL CHILD;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; ELECTROENCEPHALOGRAPHY; HUMANS; MALE; PSYCHIATRIC STATUS RATING SCALES; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 0037310915     PISSN: 01678760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8760(02)00119-8     Document Type: Article

References (37)

1. Diagnostic and Statistical Manual of Mental Disorders. fourth ed. 1994;American Psychiatric Association, Washington DC.
2. Barry, R., Clarke, A., Johnstone, S. A review of electrophysiology in Attention-deficit/Hyperactivity Disorder: I. qualitative and quantitative electroencephalography. Clin. Neurophysiol., in press.
3. Bellak L., Black R. Attention-deficit hyperactive disorder in adults. Clin. Ther. 14:1992;138-147.
4. Callaway E., Halliday R., Naylor H. Hyperactive children's event-related potentials fail to support underarousal and maturational-lag theories. Arch. Gen. Psychiatry. 40:1983;1243-1248.
5. Castellanos F., Giedd J., Marsh W., et al. Quantitative brain magnetic resonance imaging in attention-deficit hyperactivity disorder. Arch. Gen. Psychiatry. 53:1996;607-616.
6. Chabot R., Orgill A., Crawford G., Harris M., Serfontein G. Behavioural and electrophysiologic predictors of treatment response to stimulants in children with attention disorders. J. Child Neurol. 14:1999;343-351.
7. Chabot R., Serfontein G. Quantitative electroencephalographic profiles of children with attention deficit disorder. Biol. Psychiatry. 40:1996;951-963.
8. Clarke A., Barry R., McCarthy R., Selikowitz M. EEG analysis in attention-deficit/hyperactivity disorder: a comparative study of two subtypes. Psychiatry Res. 81:1998;19-29.
9. Clarke A., Barry R., McCarthy R., Selikowitz M. Age and sex effects in the EEG: development of the normal child. Clin. Neurophysiol. 112:2001a;815-826.
10. Clarke A., Barry R., McCarthy R., Selikowitz M. Age and sex effects in the EEG: differences in two subtypes of Attention-Deficit/Hyperactivity Disorder. Clin. Neurophysiol. 112:2001b;815-826.
11. Clarke A., Barry R., McCarthy R., Selikowitz M. EEG differences in two subtypes of attention-deficit/hyperactivity disorder. Psychophysiology. 38:2001c;212-221.
12. Clarke A., Barry R., McCarthy R., Selikowitz M. EEG-defined subtypes of children with Attention-Deficit/Hyperactivity Disorder. Clin. Neurophysiol. 112:2001d;2098-2105.
13. Clarke A., Barry R., McCarthy R., Selikowitz M. Excess beta in children with Attention-Deficit/Hyperactivity Disorder: an atypical electrophysiological group. Psychiatry Res. 103:2001e;205-218.
14. Clarke A., Barry R., McCarthy R., Selikowitz M., Brown C. EEG evidence for a new conceptualisation of Attention Deficit Hyperactivity Disorder. Clin. Neurophysiol. 113:2002;1036-1044.
15. Clarke, A., Barry, R., Bond, D., McCarthy, R., Selikowitz, M. Effects of stimulant medications on the EEG of children with Attention Deficit/Hyperactivity Disorder. Psychopharmacology, in press.
16. Dykman R., Holcomb P., Oglesby D., Ackerman P. Electrocortical frequencies in hyperactive, learning-disabled, mixed, and normal children. Biol. Psychiatry. 17:1982;675-685.
17. Filipek P., Semrud-Clikeman M., Steingard R., Renshaw P., Kennedy D., Biederman J. Volumetric MRI analysis comparing subjects having attention-deficit hyperactivity disorder with normal controls. Neurology. 48:1997;589-601.
18. Gordon M. How is a computerized attention test used in the diagnosis of attention deficit disorder? J. Child Contemp. Soc. 19:1986;53-64.
19. Howell D. Statistical Methods for Psychology. fourth ed. 1997;Duxbury Press, California.
20. Janzen T., Graap K., Stephanson S., Marshall W., Fitzsimmons G. Differences in baseline EEG measures for ADD and normally achieving preadolescent males. Biofeedback Self Regul. 20:1995;65-82.
21. Lazzaro I., Gordon E., Whitmont S., et al. Quantified EEG activity in adolescent attention deficit hyperactivity disorder. Clin. Electroencephalogr. 29:1998;37-42.
22. Lindgren, S., Wolraich, M., Stromquist, A., Davis, C., Milich, R., Watson, D., 1990. Diagnostic heterogeneity in attention deficit hyperactivity disorder. Presented at the Fourth Annual NIMH International Research Conference on the Classification and Treatment of Mental Disorders in General Medical Settings, Bethesda.
23. Loo S., Teale P., Reite M. EEG correlates of methylphenidate response among children with ADHD: a preliminary report. Biol. Psychiatry. 45:1999;1657-1660.
24. Lubar J. Discourse on the development of EEG diagnostics and biofeedback for attention-deficit/hyperactivity disorders. Biofeedback Self Regul. 16:1991;201-225.
25. Lubar J., White J., Swartwood M., Swartwood J. Methylphenidate effects on global and complex measures of EEG. Pediatr. Neurol. 21:1999;633-637.
26. Mann C., Lubar J., Zimmerman A., Miller C., Muenchen R. Quantitative analysis of EEG in boys with attention deficit hyperactivity disorder: controlled study with clinical implications. Pediatr. Neurol. 8:1992;30-36.
27. Matousek M., Rasmussen P., Gilberg C. EEG frequency analysis in children with so-called minimal brain dysfunction and related disorders. Adv. Biol. Psychiatry. 15:1984;102-108.
28. Pelham W., Gnagy E., Greenslade K., Milich R. Teacher ratings of DSM-III-R symptoms for the disruptive behaviour disorders. J. Am. Acad. Child Adol. Psychiatry. 31:1992;210-218.
29. Satterfield J., Cantwell D., Saul R., Lesser M., Podsin R. Physiological studies of the hyperkinetic child: I. Am. J. Psychiatry. 128:1972;102-108.
30. Spencer T., Beiderman J., Wilens T., Harding M., O'Donnell D., Griffin S. Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle. J. Am. Acad. Child Adolesc. Psychiatry. 35:1996;409-432.
31. Swanson J., McBurnett K., Wigal T., Pfiffner L. Effect of stimulant medication on children with attention deficit disorder: a 'Review of Reviews'. Except. Children. 60:1993;154-162.
32. Swanson J., Sergeant J., Taylor E., Sonuga-Barke E., Jensen P., Cantwell D. Attention-deficit hyperactivity disorder and hyperkinetic disorder. Lancet. 351:1998;429-433.
33. Swartwood M., Swartwood J., Lubar J., Timmermann D., Zimmerman A., Muenchen R. Methylphenidate effects on EEG, behavior, and performance in boys with ADHD. Pediatr. Neurol. 18:1998;244-250.
34. Tabachnick B., Fidell L. Using Multivariate Statistics. 1989;Harper Collins, New York.
35. Todd R., Botteron K. Is attention-deficit/hyperactivity disorder an energy deficiency syndrome? Biol. Psychiatry. 50:2001;151-158.
36. Ucles P., Lorente S. Elecrophysiologic measures of delayed maturation in attention-deficit hyperactivity disorder. J. Child Neurol. 11:1996;155-156.
37. Wilens T., Biederman J. The stimulants. Psychiatr. Clin. N. Am. 15:1992;191-222.